logo
Systematic review with meta‐analysis : the impact of Clostridium difficile infection on the short‐ and long‐term risks of colectomy in inflammatory bowel disease
Systematic review with meta‐analysis : placebo rates in induction and maintenance trials of Crohn's disease
Systematic review with meta‐analysis : the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases
Review article : moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis
Randomised clinical trial : the efficacy and safety of oltipraz, a liver X receptor alpha‐inhibitory dithiolethione in patients with non‐alcoholic fatty liver disease
Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten‐free diet
Predictors of response to a low‐FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance
Inflammatory bowel diseases in Faroese‐born Danish residents and their offspring : further evidence of the dominant role of environmental factors in IBD development
Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort : incidence, deployment‐related risk factors, and antecedent episodes of infectious gastroenteritis
Suppression of anti‐drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease
Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease
On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma : a multi‐centre, prospective study
Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti‐viral therapy with an interferon‐free regimen
Editorial : smoking status and 5‐year survival in patients with colorectal cancer
Editorial : scoring systems in primary biliary cholangitis – time to make a move
Editorial : scoring systems in primary biliary cholangitis – time to make a move. Authors’ reply
Editorial : elemental diets for eosinophilic oesophagitis
Editorial : co‐existing immune‐mediated disease in inflammatory bowel diseases – a new disease severity indicator?
Editorial : co‐existing immune‐mediated disease in inflammatory bowel diseases – a new disease severity indicator? Author's reply
Letter : dose optimising infliximab in acute severe ulcerative colitis
Letter : dose optimising infliximab in acute severe ulcerative colitis – authors' reply
Letter : sustained virological response and liver healing
Letter : sustained virological response and liver healing – authors' reply
Letter : NICE referral criteria for lower gastrointestinal alarm features – not ideal but not poor either
Letter : NICE referral criteria for lower gastrointestinal alarm features – not ideal but not poor either. Authors' reply
Letter : how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply
Letter : how to define remission in ulcerative colitis – histological remission should be considered